Correlation Between Small Pharma and Biotron
Can any of the company-specific risk be diversified away by investing in both Small Pharma and Biotron at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Small Pharma and Biotron into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Small Pharma and Biotron Limited, you can compare the effects of market volatilities on Small Pharma and Biotron and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Small Pharma with a short position of Biotron. Check out your portfolio center. Please also check ongoing floating volatility patterns of Small Pharma and Biotron.
Diversification Opportunities for Small Pharma and Biotron
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Small and Biotron is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Small Pharma and Biotron Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotron Limited and Small Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Small Pharma are associated (or correlated) with Biotron. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotron Limited has no effect on the direction of Small Pharma i.e., Small Pharma and Biotron go up and down completely randomly.
Pair Corralation between Small Pharma and Biotron
If you would invest 0.98 in Biotron Limited on December 29, 2024 and sell it today you would lose (0.71) from holding Biotron Limited or give up 72.45% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Small Pharma vs. Biotron Limited
Performance |
Timeline |
Small Pharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Biotron Limited |
Small Pharma and Biotron Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Small Pharma and Biotron
The main advantage of trading using opposite Small Pharma and Biotron positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Small Pharma position performs unexpectedly, Biotron can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotron will offset losses from the drop in Biotron's long position.Small Pharma vs. Cellectis SA | Small Pharma vs. Biotron Limited | Small Pharma vs. Resverlogix Corp | Small Pharma vs. Covalon Technologies |
Biotron vs. biOasis Technologies | Biotron vs. Covalon Technologies | Biotron vs. Mosaic Immunoengineering | Biotron vs. Cellectis SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |